The Newborn Metabolic Screening Programme (NMSP) Governance Team was established in 2011 following a review of the previous Advisory Group.
The Governance Team meets annually, with a smaller Technical Group meeting two to three times per year.
The role of the NMSP Governance Team is to:
The Governance Team comprises members who collectively have a wide knowledge and experience of newborn metabolic screening, including health practioners, representatives of professional organisations and consumers.
| Newborn metabolic screening technical expert | Dr Bridget Wilcken |
| Midwife | Kerry Adams |
| Consumer representative | John Forman (NZORD) |
| Public Health Physician | Dr Gary Jackson |
| Paediatricians | Dr Paul Hofman & Dr Julian Vyas |
| Chemical Pathologist | Dr Richard Mackay |
| Commissioner for Children representative | Vacant |
| Legal advisor | Dr Fiona McCrimmon |
| Geneticist | Dr Joanne Dixon |
| Maori advisor | Deb Rowe |
| Pacific/ Consumer advisor | Prof Peggy Fairbairn-Dunlop |
| NMSP metabolic physician | Dr Callum Wilson |
| NMSP director |
Dr Dianne Webster |
The role of the NMSP Technical Group is to: